BioRestorative Therapies, Inc. (NASDAQ:BRTX) Short Interest Up 129.3% in December

BioRestorative Therapies, Inc. (NASDAQ:BRTX) saw a large growth in short interest in the month of December. As of December 15th, there was short interest totalling 153,400 shares, a growth of 129.3% from the November 30th total of 66,900 shares. Based on an average daily volume of 47,600 shares, the days-to-cover ratio is currently 3.2 days. Currently, 3.0% of the shares of the company are sold short.

BioRestorative Therapies Stock Performance

BRTX remained flat at $1.55 during trading hours on Friday. The company had a trading volume of 21,982 shares, compared to its average volume of 688,456. The stock has a market capitalization of $10.73 million, a PE ratio of -1.01 and a beta of 62.52. The firm’s 50-day simple moving average is $1.52 and its two-hundred day simple moving average is $1.63. BioRestorative Therapies has a 52 week low of $1.03 and a 52 week high of $3.67.

BioRestorative Therapies (NASDAQ:BRTX) last posted its quarterly earnings data on Tuesday, November 12th. The company reported ($0.13) earnings per share for the quarter, beating the consensus estimate of ($0.35) by $0.22. The firm had revenue of $0.23 million for the quarter, compared to analysts’ expectations of $0.30 million. BioRestorative Therapies had a negative net margin of 2,697.08% and a negative return on equity of 98.49%. Analysts predict that BioRestorative Therapies will post -1.43 earnings per share for the current fiscal year.

About BioRestorative Therapies

BioRestorative Therapies, Inc, a life sciences company, focuses on the development of regenerative medicine products and therapies using cell and tissue protocols primarily involving adult stem cells. The company's two core developmental programs relate to the treatment of disc/spine disease and metabolic disorders.